These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
555 related items for PubMed ID: 17961777
41. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW. J Clin Oncol; 2005 Jul 01; 23(19):4275-86. PubMed ID: 15795415 [Abstract] [Full Text] [Related]
42. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Mery CM, George S, Bertagnolli MM, Raut CP. Cancer; 2009 Sep 15; 115(18):4055-63. PubMed ID: 19526590 [Abstract] [Full Text] [Related]
43. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. Olivotto IA, Lesperance ML, Truong PT, Nichol A, Berrang T, Tyldesley S, Germain F, Speers C, Wai E, Holloway C, Kwan W, Kennecke H. J Clin Oncol; 2009 Jan 01; 27(1):16-23. PubMed ID: 19018080 [Abstract] [Full Text] [Related]
44. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer. Tilanus-Linthorst MM, Alves C, Seynaeve C, Menke-Pluymers MB, Eggermont AM, Brekelmans CT. Br J Surg; 2006 Aug 01; 93(8):961-8. PubMed ID: 16758466 [Abstract] [Full Text] [Related]
45. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. Obedian E, Fischer DB, Haffty BG. J Clin Oncol; 2000 Jun 01; 18(12):2406-12. PubMed ID: 10856100 [Abstract] [Full Text] [Related]
46. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, Raina V. Indian J Cancer; 2004 Jun 01; 41(1):8-12. PubMed ID: 15105573 [Abstract] [Full Text] [Related]
47. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Mâsse B, Vigneault E, Vass S, del Vecchio P, Roy J. J Natl Cancer Inst; 2005 Apr 06; 97(7):481-8. PubMed ID: 15812073 [Abstract] [Full Text] [Related]
48. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. Hill-Kayser CE, Harris EE, Hwang WT, Solin LJ. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1313-9. PubMed ID: 16997501 [Abstract] [Full Text] [Related]
50. Postmastectomy radiation and survival in older women with breast cancer. Smith BD, Haffty BG, Hurria A, Galusha DH, Gross CP. J Clin Oncol; 2006 Oct 20; 24(30):4901-7. PubMed ID: 17050874 [Abstract] [Full Text] [Related]
51. Locoregional recurrence in breast carcinoma patients. Yildirim E. Eur J Surg Oncol; 2009 Mar 20; 35(3):258-63. PubMed ID: 18644692 [Abstract] [Full Text] [Related]
52. Decreased risk of stroke among 10-year survivors of breast cancer. Hooning MJ, Dorresteijn LD, Aleman BM, Kappelle AC, Klijn JG, Boogerd W, van Leeuwen FE. J Clin Oncol; 2006 Dec 01; 24(34):5388-94. PubMed ID: 17088569 [Abstract] [Full Text] [Related]
54. [Bilateral primary breast cancer: a report of 217 cases]. Zhang T, Zhang BN. Zhonghua Zhong Liu Za Zhi; 2004 Dec 01; 26(12):756-8. PubMed ID: 15733399 [Abstract] [Full Text] [Related]
55. Clinical characteristics of breast cancer patients in Korea in 2000. Ahn SH, Korean Breast Cancer Society. Arch Surg; 2004 Jan 01; 139(1):27-30; discussion 31. PubMed ID: 14718270 [Abstract] [Full Text] [Related]
57. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Gao X, Fisher SG, Emami B. Int J Radiat Oncol Biol Phys; 2003 Jul 15; 56(4):1038-45. PubMed ID: 12829139 [Abstract] [Full Text] [Related]
58. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results. Knauerhase H, Strietzel M, Gerber B, Reimer T, Fietkau R. Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1048-55. PubMed ID: 18359170 [Abstract] [Full Text] [Related]
59. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F. Cancer; 2004 Nov 01; 101(9):1977-86. PubMed ID: 15389473 [Abstract] [Full Text] [Related]
60. Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways. Vichapat V, Gillett C, Fentiman IS, Tutt A, Holmberg L, Lüchtenborg M. Eur J Cancer; 2011 Sep 01; 47(13):1919-27. PubMed ID: 21658939 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]